Joanne Reekie1, Basil Donovan1,2, Rebecca Guy1, Jane S Hocking3, John M Kaldor1, Donna B Mak4, Sallie Pearson5, David Preen6, Louise Stewart7,8, James Ward9, Bette Liu10. 1. Kirby Institute, University of New South Wales (UNSW). 2. Sydney Sexual Health Centre, Sydney Hospital. 3. School of Population and Global Health, University of Melbourne. 4. School of Medicine, University of Notre Dame, Fremantle. 5. Faculty of Pharmacy and School of Public Health, University of Sydney. 6. Centre for Health Services Research, University of Western Australia. 7. Centre for Population Health Research, Curtin University, Perth. 8. Insitute for Health Research, University of Notre Dame, Fremantle. 9. South Australian Health and Medical Research Institute, Adelaide. 10. School of Public Health and Community Medicine, UNSW, Sydney, Australia.
Abstract
Background: There is uncertainty around whether the risks of pelvic inflammatory disease (PID) differ following Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infection. We quantified the risk of PID associated with chlamydia and gonorrhea infection and subsequent repeat infections in a whole-population cohort. Methods: A cohort of 315123 Western Australian women, born during 1974-1995, was probabilistically linked to chlamydia and gonorrhea testing records and to hospitalizations and emergency department presentations for PID from 2002 to 2013. Time-updated survival analysis was used to investigate the association between chlamydia and gonorrhea testing, and positivity, and risk of PID. Results: Over 3199135 person-years, 120748 women had pathology test records for both chlamydia and gonorrhea, 10745 chlamydia only, and 653 gonorrhea only. Among those tested, 16778 (12.8%) had ≥1 positive chlamydia test, 3195 (2.6%) ≥1 positive gonorrhea test, and 1874 (1.6%) were positive for both. There were 4819 PID presentations (2222 hospitalizations, 2597 emergency presentations). Adjusting for age, Aboriginality, year of follow-up, health area, and socioeconomic status, compared to women negative for chlamydia and gonorrhea, the relative risk (adjusted incidence rate ratio) of PID was 4.29 (95% confidence interval [CI], 3.66-5.03) in women who were both chlamydia and gonorrhea positive; 4.54 (95% CI, 3.87-5.33) in those only gonorrhea positive; and 1.77 (95% CI, 1.61-1.94) in those only chlamydia positive. Conclusions: Gonorrhea infection conferred a substantially higher risk than chlamydia of hospitalization or emergency department presentation for PID. The emergence of gonorrhea antimicrobial resistance may have a serious impact on rates of PID and its associated reproductive health sequelae.
Background: There is uncertainty around whether the risks of pelvic inflammatory disease (PID) differ following Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infection. We quantified the risk of PID associated with chlamydia and gonorrhea infection and subsequent repeat infections in a whole-population cohort. Methods: A cohort of 315123 Western Australian women, born during 1974-1995, was probabilistically linked to chlamydia and gonorrhea testing records and to hospitalizations and emergency department presentations for PID from 2002 to 2013. Time-updated survival analysis was used to investigate the association between chlamydia and gonorrhea testing, and positivity, and risk of PID. Results: Over 3199135 person-years, 120748 women had pathology test records for both chlamydia and gonorrhea, 10745 chlamydia only, and 653 gonorrhea only. Among those tested, 16778 (12.8%) had ≥1 positive chlamydia test, 3195 (2.6%) ≥1 positive gonorrhea test, and 1874 (1.6%) were positive for both. There were 4819 PID presentations (2222 hospitalizations, 2597 emergency presentations). Adjusting for age, Aboriginality, year of follow-up, health area, and socioeconomic status, compared to women negative for chlamydia and gonorrhea, the relative risk (adjusted incidence rate ratio) of PID was 4.29 (95% confidence interval [CI], 3.66-5.03) in women who were both chlamydia and gonorrhea positive; 4.54 (95% CI, 3.87-5.33) in those only gonorrhea positive; and 1.77 (95% CI, 1.61-1.94) in those only chlamydia positive. Conclusions: Gonorrhea infection conferred a substantially higher risk than chlamydia of hospitalization or emergency department presentation for PID. The emergence of gonorrhea antimicrobial resistance may have a serious impact on rates of PID and its associated reproductive health sequelae.
Authors: Rodman Turpin; Susan Tuddenham; Xin He; Mark A Klebanoff; Khalil G Ghanem; Rebecca M Brotman Journal: J Infect Dis Date: 2021-08-16 Impact factor: 7.759
Authors: Kristie L Connolly; Michelle Pilligua-Lucas; Carolina Gomez; Allison C Costenoble-Caherty; Anthony Soc; Knashka Underwood; Andrew N Macintyre; Gregory D Sempowski; Ann E Jerse Journal: J Infect Dis Date: 2021-08-16 Impact factor: 7.759
Authors: Andreea Waltmann; Joseph A Duncan; Gerald B Pier; Colette Cywes-Bentley; Myron S Cohen; Marcia M Hobbs Journal: Curr Top Microbiol Immunol Date: 2022-03-05 Impact factor: 4.737
Authors: Daphne A van Wees; Janneke C M Heijne; Titia Heijman; Karlijn C J G Kampman; Karin Westra; Anne de Vries; Mirjam E E Kretzschmar; Chantal den Daas Journal: BMC Infect Dis Date: 2018-11-13 Impact factor: 3.090
Authors: Mark Thomas; Amba Lawrence; Samuel Kroon; Lenka A Vodstrcil; Samuel Phillips; Jane S Hocking; Peter Timms; Wilhelmina M Huston Journal: Access Microbiol Date: 2021-02-19
Authors: Bernice M Hoenderboom; Birgit H B van Benthem; Jan E A M van Bergen; Nicole H T M Dukers-Muijrers; Hannelore M Götz; Christian J P A Hoebe; Arjan A Hogewoning; Jolande A Land; Marianne A B van der Sande; Servaas A Morré; Ingrid V F van den Broek Journal: Sex Transm Infect Date: 2019-01-03 Impact factor: 3.519